Form 4: Beam Therapeutics CFO Terry-Ann Burrell Reports Acquisition of Common Stock and Restricted Stock Units

Chief Financial Officer Terry-Ann Burrell reports acquisition of Beam Therapeutics common stock and restricted stock units.

Summary

• On March 31, 2024, Terry-Ann Burrell, the Chief Financial Officer of Beam Therapeutics Inc., acquired 27,500 restricted stock units (RSUs) and additional shares of common stock through the company's employee stock purchase plan.
• The RSUs vest in four equal installments annually from the grant date.
• Following these transactions, Burrell directly owns 75,583 shares of Beam Therapeutics common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard compensation practices (RSUs) and participation in an employee stock purchase plan, indicating confidence in the company's future.

Positives

• The acquisition of shares through the employee stock purchase plan demonstrates the CFO's investment in the company's future.
• The granting of RSUs aligns the CFO's interests with the long-term performance of the company.

Future Outlook

The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider ownership.
• Employees may be impacted by the existence of the employee stock purchase plan.

Key Dates